局部晚期胰腺癌内脏动脉间置移植重建的结局
回顾性分析2002年6月至2022年10月因胰腺癌行整块动脉切除联合间置血管重建的111例患者,90天死亡率近6年降至5%,动脉重建相关血管并发症发生率为11%,中位随访17个月时总体初级通畅率为81%,自体股浅动脉组最高达95%。
要点
- 111例胰腺癌整块动脉切除联合间置重建,90天死亡率近6年降至5%。
- 动脉重建相关血管并发症发生率11%,血管相关再干预率8%。
- 中位随访17个月总体初级通畅率81%,自体股浅动脉组最高95%。
核心结论
- 局部晚期胰腺癌行内脏动脉切除联合间置重建的血管并发症可接受且通畅持久。
- 作者经验中自体股浅动脉是最合适的重建管道,初级通畅率最高。
研究设计与样本
- 回顾性综述,纳入2002年6月至2022年10月因胰腺癌行整块动脉切除联合间置血管重建的患者111例。
- 终点包括移植物通畅性、血管相关并发症、再干预、发病率和死亡率。
主要发现
- 移植物类型包括自体动脉管道66例(股浅动脉58例、脾动脉8例)、冷冻保存动脉同种异体移植物24例、自体大隐静脉12例、合成管道8例、自体动脉与合成复合移植物1例。
- 围手术期90天死亡率随时间显著下降,近6年为5%。
- 动脉重建相关血管并发症发生率为11%(n=12),包括假性动脉瘤6例、移植物血栓2例、需再干预的狭窄2例、肝衰竭1例、肝及肠道缺血1例。
- 9例(8%)患者接受了血管相关再干预。
- 中位随访17个月,整个队列初级通畅率为81%,股浅动脉组最高为95%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study is to determine perioperative outcomes and the patency of interposition conduits for visceral arterial reconstruction in this setting. BACKGROUND: Visceral arterial encasement in locally advanced pancreatic cancer was historically a contraindication for surgery. With modern, effective neoadjuvant strategies, our recent experience has made advanced vascular resection and reconstruction feasible in selected patients. METHODS: A retrospective review was performed of patients undergoing pancreatic tumor resection with en bloc arterial resection and interposition revascularization between June 2002 and October 2022. Endpoints included graft patency, vascular-related complications, reinterventions, morbidity, and mortality. RESULTS: Visceral arterial reconstruction with interposition grafting was performed in 111 patients undergoing en bloc arterial resections for pancreatic cancer. Graft types included autologous arterial conduits (n=66, 58 superficial femoral arteries (SFA) and 8 splenic arteries), cryopreserved arterial allografts (n=24), autologous saphenous veins (n=12), synthetic conduits (n=8), and composite autologous artery and synthetic (n=1). Perioperative 90-day mortality decreased significantly over time to 5% in the last 6 years. Vascular complications related to arterial reconstruction occurred in 11% (n=12) and included pseudoaneurysm (n=6), graft thrombus (n=2), stenosis requiring reintervention (n=2), hepatic failure (n=1), and hepatic and intestinal ischemia (n=1). Nine (8%) patients underwent vascular-related reinterventions. After a median follow-up of 17 months, primary patency was 81% for the entire cohort and was highest in the SFA group (95%). The donor limb/harvest site complication rate was 8% with 100% primary patency. CONCLUSION: Visceral arterial resection with interposition reconstruction for locally advanced pancreatic cancer can be performed with acceptable vascular morbidity and durable patency. Autologous SFA was the most suitable conduit for reconstructions in our experience, with the highest primary patency.
引用
- Yonkus JA, Alva-Ruiz R, Colglazier JJ, et al. Outcomes of Visceral Arterial Interposition Graft Reconstruction for Locally Advanced Pancreatic Cancer. Ann Surg. 2024. PMID: 38771952. doi:10.1097/SLA.0000000000006350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。